Last year, U.S. regulators approved an islet celltherapy from organ donors. But use of the treatment is far from mainstream. Researchers looked to the field of stemcell research to solve the ...
Its lead product is NeuroNata-R (lenzumestrocel), the world’s first stemcell-based therapy for amyotrophic lateral sclerosis (ALS). NeuroNata-R was approved as an orphan drug for the treatment ...